Identifcation of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA‑Seq

Alternative splicing isoforms have been reported as a new and robust class of diagnostic biomarkers. Over 95% of human genes are estimated to be alternatively spliced as a powerful means of producing functionally diverse proteins from a single gene.